PROTO LABS INC (PRLB) Fundamental Analysis & Valuation

NYSE:PRLB • US7437131094

57.59 USD
+0.25 (+0.44%)
At close: Mar 9, 2026
57.87 USD
+0.28 (+0.49%)
After Hours: 3/9/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This PRLB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, PRLB scores 4 out of 10 in our fundamental rating. PRLB was compared to 131 industry peers in the Machinery industry. PRLB has a great financial health rating, but its profitability evaluates not so good. PRLB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. PRLB Profitability Analysis

1.1 Basic Checks

  • PRLB had positive earnings in the past year.
  • PRLB had a positive operating cash flow in the past year.
  • Of the past 5 years PRLB 4 years were profitable.
  • PRLB had a positive operating cash flow in each of the past 5 years.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.78%, PRLB is in line with its industry, outperforming 44.27% of the companies in the same industry.
  • With a Return On Equity value of 3.15%, PRLB perfoms like the industry average, outperforming 41.22% of the companies in the same industry.
  • With a Return On Invested Capital value of 2.55%, PRLB is not doing good in the industry: 67.18% of the companies in the same industry are doing better.
  • PRLB had an Average Return On Invested Capital over the past 3 years of 2.57%. This is significantly below the industry average of 10.16%.
Industry RankSector Rank
ROA 2.78%
ROE 3.15%
ROIC 2.55%
ROA(3y)2.41%
ROA(5y)-0.41%
ROE(3y)2.7%
ROE(5y)-0.54%
ROIC(3y)2.57%
ROIC(5y)2.67%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • PRLB's Profit Margin of 3.98% is in line compared to the rest of the industry. PRLB outperforms 47.33% of its industry peers.
  • PRLB's Profit Margin has declined in the last couple of years.
  • PRLB has a Operating Margin of 4.91%. This is in the lower half of the industry: PRLB underperforms 62.60% of its industry peers.
  • PRLB's Operating Margin has declined in the last couple of years.
  • PRLB has a better Gross Margin (44.48%) than 84.73% of its industry peers.
  • In the last couple of years the Gross Margin of PRLB has declined.
Industry RankSector Rank
OM 4.91%
PM (TTM) 3.98%
GM 44.48%
OM growth 3Y-3.73%
OM growth 5Y-18.62%
PM growth 3YN/A
PM growth 5Y-19.41%
GM growth 3Y0.27%
GM growth 5Y-2.37%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. PRLB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
  • PRLB has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PRLB has been reduced compared to 5 years ago.
  • PRLB has a better debt/assets ratio than last year.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 10.66 indicates that PRLB is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of PRLB (10.66) is better than 94.66% of its industry peers.
  • PRLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.66
ROIC/WACC0.27
WACC9.36%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • PRLB has a Current Ratio of 3.49. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
  • PRLB's Current ratio of 3.49 is amongst the best of the industry. PRLB outperforms 83.21% of its industry peers.
  • A Quick Ratio of 3.27 indicates that PRLB has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.27, PRLB belongs to the best of the industry, outperforming 88.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.49
Quick Ratio 3.27
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PRLB Growth Analysis

3.1 Past

  • PRLB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.23%.
  • PRLB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.99% yearly.
  • The Revenue has been growing slightly by 6.44% in the past year.
  • PRLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.18% yearly.
EPS 1Y (TTM)1.23%
EPS 3Y3.23%
EPS 5Y-6.99%
EPS Q2Q%15.79%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y2.96%
Revenue growth 5Y4.18%
Sales Q2Q%12.11%

3.2 Future

  • PRLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.67% yearly.
  • PRLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.40% yearly.
EPS Next Y11%
EPS Next 2Y10.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.92%
Revenue Next 2Y7.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. PRLB Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 34.90, PRLB can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, PRLB is valued a bit more expensive than the industry average as 60.31% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 26.46, PRLB is valued a bit more expensive.
  • With a Price/Forward Earnings ratio of 31.44, PRLB can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, PRLB is valued a bit more expensive than 63.36% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of PRLB to the average of the S&P500 Index (24.65), we can say PRLB is valued slightly more expensively.
Industry RankSector Rank
PE 34.9
Fwd PE 31.44
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • PRLB's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PRLB is more expensive than 63.36% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PRLB is valued a bit cheaper than the industry average as 65.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.95
EV/EBITDA 20.3
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRLB does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.17
PEG (5Y)N/A
EPS Next 2Y10.67%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PRLB Dividend Analysis

5.1 Amount

  • PRLB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRLB Fundamentals: All Metrics, Ratios and Statistics

PROTO LABS INC

NYSE:PRLB (3/9/2026, 8:04:00 PM)

After market: 57.87 +0.28 (+0.49%)

57.59

+0.25 (+0.44%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-06
Earnings (Next)04-30
Inst Owners93%
Inst Owner Change0.04%
Ins Owners1.21%
Ins Owner Change1.44%
Market Cap1.37B
Revenue(TTM)533.13M
Net Income(TTM)21.24M
Analysts78.18
Price Target73.1 (26.93%)
Short Float %2.3%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)17.55%
Max EPS beat(2)25.69%
EPS beat(4)4
Avg EPS beat(4)17.98%
Min EPS beat(4)10.87%
Max EPS beat(4)25.69%
EPS beat(8)8
Avg EPS beat(8)20.61%
EPS beat(12)12
Avg EPS beat(12)26.35%
EPS beat(16)15
Avg EPS beat(16)23.81%
Revenue beat(2)1
Avg Revenue beat(2)1.42%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)3.68%
Revenue beat(4)3
Avg Revenue beat(4)1.57%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)3.68%
Revenue beat(8)5
Avg Revenue beat(8)0.65%
Revenue beat(12)7
Avg Revenue beat(12)0.94%
Revenue beat(16)8
Avg Revenue beat(16)0.42%
PT rev (1m)26.47%
PT rev (3m)26.47%
EPS NQ rev (1m)11.74%
EPS NQ rev (3m)11.74%
EPS NY rev (1m)8.23%
EPS NY rev (3m)8.23%
Revenue NQ rev (1m)2.04%
Revenue NQ rev (3m)2.04%
Revenue NY rev (1m)2.91%
Revenue NY rev (3m)2.91%
Valuation
Industry RankSector Rank
PE 34.9
Fwd PE 31.44
P/S 2.57
P/FCF 22.95
P/OCF 18.38
P/B 2.03
P/tB 3.59
EV/EBITDA 20.3
EPS(TTM)1.65
EY2.87%
EPS(NY)1.83
Fwd EY3.18%
FCF(TTM)2.51
FCFY4.36%
OCF(TTM)3.13
OCFY5.44%
SpS22.42
BVpS28.34
TBVpS16.04
PEG (NY)3.17
PEG (5Y)N/A
Graham Number32.44
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 3.15%
ROCE 3.76%
ROIC 2.55%
ROICexc 3.13%
ROICexgc 6.45%
OM 4.91%
PM (TTM) 3.98%
GM 44.48%
FCFM 11.19%
ROA(3y)2.41%
ROA(5y)-0.41%
ROE(3y)2.7%
ROE(5y)-0.54%
ROIC(3y)2.57%
ROIC(5y)2.67%
ROICexc(3y)3.06%
ROICexc(5y)3.08%
ROICexgc(3y)6.13%
ROICexgc(5y)6.26%
ROCE(3y)3.79%
ROCE(5y)3.94%
ROICexgc growth 3Y6.83%
ROICexgc growth 5Y-9.17%
ROICexc growth 3Y3.69%
ROICexc growth 5Y-16.32%
OM growth 3Y-3.73%
OM growth 5Y-18.62%
PM growth 3YN/A
PM growth 5Y-19.41%
GM growth 3Y0.27%
GM growth 5Y-2.37%
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43.89%
Cap/Sales 2.78%
Interest Coverage 451.74
Cash Conversion 124.14%
Profit Quality 280.88%
Current Ratio 3.49
Quick Ratio 3.27
Altman-Z 10.66
F-Score7
WACC9.36%
ROIC/WACC0.27
Cap/Depr(3y)48.14%
Cap/Depr(5y)56.79%
Cap/Sales(3y)3.4%
Cap/Sales(5y)4.33%
Profit Quality(3y)318.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.23%
EPS 3Y3.23%
EPS 5Y-6.99%
EPS Q2Q%15.79%
EPS Next Y11%
EPS Next 2Y10.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.44%
Revenue growth 3Y2.96%
Revenue growth 5Y4.18%
Sales Q2Q%12.11%
Revenue Next Year7.92%
Revenue Next 2Y7.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.77%
EBIT growth 3Y-0.87%
EBIT growth 5Y-15.21%
EBIT Next Year112.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.11%
FCF growth 3Y13.88%
FCF growth 5Y-0.11%
OCF growth 1Y-4.27%
OCF growth 3Y6.26%
OCF growth 5Y-6.98%

PROTO LABS INC / PRLB FAQ

Can you provide the ChartMill fundamental rating for PROTO LABS INC?

ChartMill assigns a fundamental rating of 4 / 10 to PRLB.


What is the valuation status of PROTO LABS INC (PRLB) stock?

ChartMill assigns a valuation rating of 1 / 10 to PROTO LABS INC (PRLB). This can be considered as Overvalued.


What is the profitability of PRLB stock?

PROTO LABS INC (PRLB) has a profitability rating of 3 / 10.


What is the financial health of PROTO LABS INC (PRLB) stock?

The financial health rating of PROTO LABS INC (PRLB) is 9 / 10.


Can you provide the expected EPS growth for PRLB stock?

The Earnings per Share (EPS) of PROTO LABS INC (PRLB) is expected to grow by 11% in the next year.